Research reading
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale demand and the South Korea (KOR) to Malaysia (MYS) lane
Malaysia (MYS) reported $611.0K of blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale imports in 2021. South Korea (KOR) accounted for 4.3% of the observed market and reported $22.2K in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +43.3% buyer growth and +30.1% exporter growth. The page separates reported values from projections and indicators.
